SOURCE: Stock Market Alerts

May 23, 2007 09:20 ET

Stock Alert for BTEM! May 23, 2007

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Stock Market Alerts.

MIAMI, FL--(Marketwire - May 23, 2007) - Stock Market Alerts' performance stock list includes: BioStem, Inc. (OTCBB: BTEM), Genentech, Inc. (NYSE: DNA), Cerner Corp. (NASDAQ: CERN), Energy Conversion Devices, Inc. (NASDAQ: ENER).

BioStem, Inc. (OTCBB: BTEM) is on the move and continues to issue good news, which should be of interest to investors. The company issued a press release this morning announcing that Cryobanks International (Cryobanks), which has agreed to be acquired by BioStem, Inc., has implemented an expansion to its global marketing campaign due to the heightened demand for licensing of its world-recognized cord blood technology.

Additional great news for BTEM investors! The press release also states that in addition to the eight facilities presently under contract, the marketing & sales campaign will now encompass over 11 countries with revenue projections exceeding $25M.

Cryobanks, which possess one of the world's largest cord blood stem cell inventories, intends to implement its cord blood technology through multiple international licensing agreements through representation by contracted industry experts. Through each licensing agreement, Cryobanks will receive large initial compensation as well as annual royalties.

According to Cryobanks' CEO, Dwight Brunoehler, "The overwhelming demand for the unique service that Cryobanks provides taxes our in-house staff to the limit. Having local representation on the ground in each targeted country will help to identify and prioritize our opportunities."

At the time of writing, Cryobanks has facilities in Athens, Greece and Delhi, India. Of the eight facilities under contract, the Bangkok, Thailand location is expected to open within the next 60 days. Detailed revenue breakdowns as well as progress updates covering the presently operating facilities will be released in the near future.

This is certainly another company for investors to watch closely! On Monday, the company also announced that Cryobanks International, Inc. has experienced remarkable growth as its organization announces an increase of over 300 percent in the past four years.

BTEM stock closed Tuesday at $2.39 a share.

Cryobanks International is located in Altamonte Springs, FL. The Company is a leader in the collection, processing, and banking of stem cells derived from the umbilical cord immediately after birth. The units of cord blood (CB) are processed and stored by the company for use in unrelated transplants (where the donor is a histocompatible match, but is anonymous and unrelated to the recipient) and for personal storage and use. In recent years, cord blood transplants (CBTs) have become widely recognized as a safe, effective, and in many ways preferable, alternative to bone marrow transplant. There is tremendous potential need for CBTs in the United States and worldwide. Cryobanks International is well poised to help meet that need, equipped with an inventory of over 9,700 donated cord blood units placed on international registries including The National Marrow Donor Program.

Other Stocks of interest yesterday were:

Genentech, Inc. (NYSE: DNA) up 1.5% on 4.1 million shares traded. Genentech, Inc. is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.

Cerner Corp.'s (NASDAQ: CERN) up 6.7% on 3.6 million shares traded. Cerner Corp. is taking the paper chart out of healthcare, eliminating error, variance and waste in the care process. With more than 6,000 clients worldwide, Cerner is the leading supplier of healthcare information technology.

Energy Conversion Devices, Inc. (NASDAQ: ENER) up 6.6% on 2.3 million shares traded. Energy Conversion Devices is the leader in the synthesis of new materials and the development of advanced production technology and innovative alternative energy products and solutions.

The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company." The company received compensation for services performed for BioStem, Inc. (OTCBB: BTEM). The compensation was twelve thousand dollars in 2007 from third party, ATN Enterprises, who is non-affiliated and may hold a significant position in the stock. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.

The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.

The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.

Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.

This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.

Contact Information